ES2054815T3 - Citoquinas insolubilizadas en agua. - Google Patents
Citoquinas insolubilizadas en agua.Info
- Publication number
- ES2054815T3 ES2054815T3 ES88307610T ES88307610T ES2054815T3 ES 2054815 T3 ES2054815 T3 ES 2054815T3 ES 88307610 T ES88307610 T ES 88307610T ES 88307610 T ES88307610 T ES 88307610T ES 2054815 T3 ES2054815 T3 ES 2054815T3
- Authority
- ES
- Spain
- Prior art keywords
- insolubilized
- cytokines
- water
- cytokine
- acting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
Abstract
LAS CITOQUINAS SON INSOLUBILIZADAS EN AGUA HACIENDO ACTUAR UNA PROTEINA FISIOLOGICAMENTE ADAPTABLE O ACIDO ORGANICO DE ELEVADO PESO MOLECULAR SOBRE UNA CITOQUINA, Y LAS CITOQUINAS INSOLUBILIZADAS EN AGUA ASI OBTENIDAS RETIENEN ACTIVIDAD FISIOLOGICA, Y POR CONSIGUIENTE LAS CITOQUINAS INSOLUBILIZADAS EN AGUA SON UTILES COMO INYECCIONES DE LIBERACION SOSTENIDA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22438187 | 1987-09-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2054815T3 true ES2054815T3 (es) | 1994-08-16 |
Family
ID=16812859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES88307610T Expired - Lifetime ES2054815T3 (es) | 1987-09-08 | 1988-08-17 | Citoquinas insolubilizadas en agua. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0307097B1 (es) |
AT (1) | ATE90205T1 (es) |
CA (1) | CA1326816C (es) |
DE (1) | DE3881615T2 (es) |
ES (1) | ES2054815T3 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2650502B1 (fr) * | 1989-08-07 | 1994-05-27 | Delagrange Laboratoires | Nouvelle forme galenique orale ameliorant la biodisponibilite |
CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
WO1992011844A1 (en) * | 1991-01-03 | 1992-07-23 | Alkermes Controlled Therapeutics, Inc. | Stabilization of proteins by cationic biopolymers |
US5344644A (en) * | 1991-08-01 | 1994-09-06 | Takeda Chemical Industries, Ltd. | Water-soluble composition for sustained-release |
US5912015A (en) * | 1992-03-12 | 1999-06-15 | Alkermes Controlled Therapeutics, Inc. | Modulated release from biocompatible polymers |
US5711968A (en) | 1994-07-25 | 1998-01-27 | Alkermes Controlled Therapeutics, Inc. | Composition and method for the controlled release of metal cation-stabilized interferon |
AU5669894A (en) * | 1992-11-16 | 1994-06-08 | Corporation Of Mercer University | Compositions using microencapsulated neutralizing antibodies |
CA2230494A1 (en) * | 1995-08-31 | 1997-03-06 | Alkermes Controlled Therapeutics Inc. | Composition for sustained release of an agent |
US20030190307A1 (en) | 1996-12-24 | 2003-10-09 | Biogen, Inc. | Stable liquid interferon formulations |
DE19841698A1 (de) * | 1998-09-11 | 2000-03-16 | Curative Technologies Gmbh | Wachstumsfaktor-enthaltende Zusammensetzung zur Heilung von Gewebeschäden |
US6465425B1 (en) | 2000-02-10 | 2002-10-15 | Alkermes Controlled Therapeutics, Inc. | Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins |
JP2002003398A (ja) * | 2000-04-17 | 2002-01-09 | Ltt Institute Co Ltd | 徐放製剤、その製造法及びワクチン |
DE202013011988U1 (de) * | 2012-05-15 | 2015-04-01 | Rajesh Shah | Entzündungshemmende Rezeptur |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8762982A (en) * | 1981-07-02 | 1983-02-02 | Walton, A.G. | Glycosaminoglycan drug complexes |
EP0138216B1 (en) * | 1983-10-14 | 1993-01-07 | Sumitomo Pharmaceuticals Company, Limited | Sustained-release ifn preparation for parenteral administration |
DE3484584D1 (de) * | 1983-10-14 | 1991-06-20 | Sumitomo Pharma | Injektionen mit verzoegerter abgabe. |
ES2054613T3 (es) * | 1985-12-27 | 1994-08-16 | Sumitomo Pharma | Un metodo para preparar una formulacion de liberacion mantenida. |
US4832686A (en) * | 1986-06-24 | 1989-05-23 | Anderson Mark E | Method for administering interleukin-2 |
US4853218A (en) * | 1987-02-24 | 1989-08-01 | Schering Corporation | Zinc-protamine-alpha interferon complex |
-
1988
- 1988-08-17 ES ES88307610T patent/ES2054815T3/es not_active Expired - Lifetime
- 1988-08-17 AT AT88307610T patent/ATE90205T1/de not_active IP Right Cessation
- 1988-08-17 EP EP88307610A patent/EP0307097B1/en not_active Expired - Lifetime
- 1988-08-17 DE DE8888307610T patent/DE3881615T2/de not_active Expired - Fee Related
- 1988-09-07 CA CA000576628A patent/CA1326816C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0307097B1 (en) | 1993-06-09 |
CA1326816C (en) | 1994-02-08 |
EP0307097A2 (en) | 1989-03-15 |
EP0307097A3 (en) | 1989-10-11 |
ATE90205T1 (de) | 1993-06-15 |
DE3881615T2 (de) | 1993-09-23 |
DE3881615D1 (de) | 1993-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68910262T2 (de) | Zusammenfaltbarer blutsammler. | |
DE3850492T2 (de) | Chirurgisches bewässerungs- und absaugesystem. | |
NO900947D0 (no) | Stablebar stol. | |
ES2054815T3 (es) | Citoquinas insolubilizadas en agua. | |
DE69013311T2 (de) | Stethoskop mit Kopfmembranvorsatz. | |
DE3884292D1 (de) | Bipolarer Transistor mit Heteroübergang. | |
DE3884517D1 (de) | Biologisch aktive carbonsaeureester. | |
DE3869371D1 (de) | Spritzenpumpe. | |
DE68920797T2 (de) | Herzmittel. | |
DE3771611D1 (de) | Butensaeure-n-phenylamide mit pharmazeutischen eigenschaften. | |
DE284243T1 (de) | Aseptische irrigationsspritze. | |
DE3779814D1 (de) | Insektentoetende n-substituierte-n'-substituierte-n,n'-diacylhydrazine. | |
DE68901424D1 (de) | Verbindungen mit bronchodilatatorischer aktivitaet. | |
DE68913498T2 (de) | 1,1-dioxo-cephem-4-carbothiolsäure-derivate. | |
NO895099D0 (no) | Heteroatom-inneholdende perfluoralkylterminerte neopentylsyrer og salter derav. | |
IT8722218A0 (it) | Ftalazino derivati ad attivita'farmaceutica. | |
ATE106393T1 (de) | Imidate mit insektizider wirkung. | |
YU79189A (sh) | Derivati prourokinaze z nizko molekulsko maso | |
IT8620027A0 (it) | Tripeptide ad attivita'immunostimolante. | |
ES2023410B3 (es) | Acidos 1,3,4,9-tetrahidropiran 3,4-b]indol -1 aceticos sustituidos. | |
DE3867780D1 (de) | 4-h-chinolizin-4-on-derivate mit therapeutischer aktivitaet. | |
NO880088D0 (no) | 2,1-benzotiazepin-2,2-dioksyd-5-karboksylsyrederivater. | |
NO881749D0 (no) | Roerkobling. | |
ES1005075Y (es) | Mesa de billar articulada. | |
ATE67674T1 (de) | Pharmazeutische zubereitungen mit heilender aktivitaet. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 307097 Country of ref document: ES |